Retrospective Study on Epidemiology of Colorectal Lesions

March 5, 2018 updated by: Leonardo Zorron Cheng Tao Pu, Lyell McEwin Hospital
Retrospective analysis on colonoscopies in the endoscopy unit of the Lyell McEwin Hospital.

Study Overview

Status

Completed

Conditions

Detailed Description

Colonoscopy reports will be manually searched by the investigator to evaluate epidemiology on colorectal lesions.

Study Type

Observational

Enrollment (Actual)

2658

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All colonoscopies performed in Lyell McEwin Hospital between 2010 and 2016.

Description

Inclusion Criteria:

  • Colonoscopies performed in Lyell McEwin Hospital between 2010-2016

Exclusion Criteria:

  • Sigmoidoscopies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients with colorectal lesions
Patients with a full colonoscopy that showed either a cancer or a polyp.
Patients without colorectal lesions
Patients with a full colonoscopy that showed no polyps.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adenoma detection rate
Time Frame: Day 1
Percentage of screening patients with at least one adenomatous lesion found - to be compared between Gastroenterologists and Surgeons and based on scheduling of the procedure
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SSA/P detection rate
Time Frame: Day 1
Percentage of screening patients with at least one SSA/P found - to be compared between Gastroenterologists and Surgeons and based on scheduling of the procedure
Day 1
Polyp detection rate
Time Frame: Day 1
Percentage of screening patients with at least one polyp found - to be compared between Gastroenterologists and Surgeons and based on scheduling of the procedure
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Lyell McEwin Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 15, 2017

Primary Completion (ACTUAL)

February 15, 2018

Study Completion (ACTUAL)

March 5, 2018

Study Registration Dates

First Submitted

January 25, 2017

First Submitted That Met QC Criteria

January 26, 2017

First Posted (ESTIMATE)

January 27, 2017

Study Record Updates

Last Update Posted (ACTUAL)

March 7, 2018

Last Update Submitted That Met QC Criteria

March 5, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SSA/17/NALHN/3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonic Polyp

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe